SEI Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$706M Buy
767,347
+123,343
+19% +$125M 0.65% 18
2025
Q4
$692M Buy
644,004
+81,659
+15% +$78.1M 0.68% 18
2025
Q3
$429M Sell
562,345
-106,987
-16% -$79.6M 0.46% 33
2025
Q2
$522M Sell
669,332
-6,968
-1% -$5.41M 0.6% 23
2025
Q1
$559M Buy
676,300
+146,051
+28% +$122M 0.72% 19
2024
Q4
$409M Sell
530,249
-17,699
-3% -$14.7M 0.53% 29
2024
Q3
$485M Buy
547,948
+58,759
+12% +$52.8M 0.63% 21
2024
Q2
$443M Buy
489,189
+23,692
+5% +$19M 0.63% 21
2024
Q1
$362M Sell
465,497
-787
-0.2% -$560K 0.53% 28
2023
Q4
$272M Sell
466,284
-7,173
-2% -$4.19M 0.44% 41
2023
Q3
$254M Buy
473,457
+36,821
+8% +$19M 0.46% 40
2023
Q2
$205M Buy
436,636
+82,691
+23% +$34.7M 0.36% 52
2023
Q1
$122M Buy
353,945
+57,891
+20% +$19.5M 0.23% 81
2022
Q4
$108M Sell
296,054
-64,456
-18% -$22.9M 0.24% 74
2022
Q3
$117M Buy
360,510
+4,475
+1% +$1.42M 0.26% 61
2022
Q2
$116M Buy
356,035
+21,034
+6% +$6.31M 0.25% 66
2022
Q1
$96.2M Buy
335,001
+13,389
+4% +$3.45M 0.19% 89
2021
Q4
$89M Buy
321,612
+15,326
+5% +$3.89M 0.17% 113
2021
Q3
$70.5M Buy
306,286
+2,842
+0.9% +$701K 0.15% 134
2021
Q2
$69.6M Sell
303,444
-26,330
-8% -$5.29M 0.15% 122
2021
Q1
$60.6M Sell
329,774
-177,488
-35% -$34.7M 0.15% 119
2020
Q4
$85.7M Buy
507,262
+5,788
+1% +$864K 0.22% 77
2020
Q3
$74.2M Sell
501,474
-76,250
-13% -$11.8M 0.21% 82
2020
Q2
$94.7M Buy
577,724
+55,041
+11% +$8.45M 0.29% 56
2020
Q1
$72.5M Buy
522,683
+114,950
+28% +$15.8M 0.27% 64
2019
Q4
$53.6M Sell
407,733
-60,071
-13% -$6.96M 0.16% 113
2019
Q3
$52.2M Buy
467,804
+31,538
+7% +$3.51M 0.13% 134
2019
Q2
$48.3M Sell
436,266
-168,055
-28% -$19.8M 0.16% 115
2019
Q1
$78.5M Buy
604,321
+38,779
+7% +$4.72M 0.26% 60
2018
Q4
$61.3M Buy
565,542
+20,384
+4% +$2.28M 0.22% 79
2018
Q3
$58.5M Sell
545,158
-76,099
-12% -$7.61M 0.21% 80
2018
Q2
$53M Sell
621,257
-29,656
-5% -$2.44M 0.18% 98
2018
Q1
$50.4M Sell
650,913
-503,703
-44% -$40.6M 0.19% 97
2017
Q4
$97.5M Sell
1,154,616
-138,156
-11% -$11.8M 0.34% 50
2017
Q3
$111M Buy
1,292,772
+112,532
+10% +$9.23M 0.39% 43
2017
Q2
$97.1M Buy
1,180,240
+12,764
+1% +$1.04M 0.39% 41
2017
Q1
$98.2M Buy
1,167,476
+297,277
+34% +$23.8M 0.43% 33
2016
Q4
$64M Buy
870,199
+146,053
+20% +$10.9M 0.31% 54
2016
Q3
$58.1M Buy
724,146
+623,367
+619% +$49.9M 0.3% 69
2016
Q2
$7.94M Sell
100,779
-16,681
-14% -$1.26M 0.05% 482
2016
Q1
$8.46M Buy
117,460
+31,778
+37% +$2.4M 0.05% 441
2015
Q4
$7.22M Sell
85,682
-5,986
-7% -$497K 0.04% 510
2015
Q3
$7.67M Sell
91,668
-53,430
-37% -$4.51M 0.07% 325
2015
Q2
$12.1M Sell
145,098
-36,854
-20% -$2.81M 0.11% 219
2015
Q1
$13.2M Buy
181,952
+57,216
+46% +$4.07M 0.11% 212
2014
Q4
$8.61M Buy
+124,736
New +$8.42M 0.08% 302

Other funds holding LLY

SEI Investments's LLY Position: Q1 2026 in Review

SEI Investments increased its Eli Lilly (LLY) stake by 19% in Q1 2026, buying an estimated $125M and bringing the position to 767,347 shares worth $706M. The position accounts for 0.65% of the portfolio, ranked #18.

SEI Investments first reported a position in LLY in Q4 2014 and has held it in 46 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SEI Investments held 767,347 shares of Eli Lilly worth $706M as of Q1 2026.
  • SEI Investments bought 123,343 Eli Lilly shares in Q1 2026, an estimated $125M.
  • Eli Lilly made up 0.65% of SEI Investments's portfolio in Q1 2026, its #18 holding.
  • SEI Investments first reported a position in Eli Lilly in Q4 2014 and has held it in 46 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.